Transcellular formation of thromboxane A2 in mixed incubations of endothelial cells and aspirin-treated platelets strongly depends on the prostaglandin I-synthase activity

Thrombosis Research

Volumn 99, Issue 2, 2000, Pages 155-164

  Camacho, Mercedes ^a   Vila, Luís ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Aspirin; Cyclooxygenase 2; Endothelial cell; HUVEC; Interleukin 1; PGI synthase; Platelet; Prostacyclin s ynthase; Thromboxane A2; Transcellular biosynthesis

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; UNSTABLE ANGINA PECTORIS; WESTERN BLOTTING;

ASPIRIN; BLOOD PLATELETS; COCULTURE TECHNIQUES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; FATTY ACIDS, UNSATURATED; HUMANS; INTERLEUKIN-1; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RNA, MESSENGER; THROMBOXANE A2;

EID: 0034661364     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00241-3     Document Type: Article

References (25)

1. 2 Science. 193:1976;1135-1137.
2. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem. 25:1994;5693-5698.
3. Hirsh P.D., Hillis L.D., Campbell W.B., Firth B.G., Willerson J.T. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 304:1981;685-691.
4. Fitzgerald D.J., Roy L., Catella F., Fitzgerald G.A. Platelet activation in unstable coronary disease. N Engl J Med. 315:1986;983-989.
5. Roth G.J., Stanford N., Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA. 72:1975;3073-3076.
6. Lecomte M., Laneuville O., Ji C., Dewitt D.L., Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 269:1994;13207-13215.
7. Vejar M., Fragasso G., Hackett D., Lipkin D.P., Maseri A., Born G.V.R., Ciabattoni G., Patrono C. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost. 63:1990;163-168.
8. Cipollone F., Patrignani P., Greco A., Panara M.R., Padovano R., Cuccurullo F., Patrono C., Rebuzzi A.G., Liuzzo G., Quaranta G., Maseri A. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 96:1997;1109-1116.
9. Karim S., Habib A., Levy-Toledano S., Maclouf J. Cyclooxygenases-1 and -2 of endothelial cells utilize exogenous or endogenousarachidonic acid for transcellular production of thromboxane. J Biol Chem. 271:1996;12042-12048.
10. Camacho M., López-Belmonte J., Vila L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ Res. 83:1998;353-365.
11. Hla T., Ristimäki A., Appleby S., Barriocanal J.G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci. 696:1993;197-204.
12. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA. 89:1992;7384-7388.
13. Jones D.A., Carlton D., McIntyre M.T., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 268:1993;9049-9054.
14. Camacho M., Godessart N., Antón R., García M., Vila L. Interleukin-1 enhances the ability of cultured umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem. 270:1995;17279-17286.
15. Baker C.S.R., Hall R.J.C., Evans T.J., Pomerance A., Maclouf J., Creminon C., Yacoub M.H., Polak J.M. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol. 19:1999;646-655.
16. 2 biosynthesis. J Biol Chem. 264:1989;141-150.
17. Vila L., Cullaré C., Solá J., Puig L., De Castellarnau C., De Moragas J.M. Cyclooxygenase activity is increased in platelets from psoriatic patients. J Invest Dermatol. 97:1991;922-926.
18. 4 by transcellular biosynthesis. J Invest Dermatol. 98:1992;333-339.
19. Godessart N., Camacho M., López-Belmonte J., Antón R., García M., De Moragas J.-M., Vila L. Prostaglandin H-synthase-2 is the main enzyme involved in the biosynthesis of octadecanoids from linoleic acid in human dermal fibroblasts stimulated with IL-1β J Invest Dermatol. 107:1996;726-732.
20. Miralpeix M., Camacho M., López-Belmonte J., Canalías F., Beleta J., Palacios J.M., Vila L. Selective induction of cyclooxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C. biochemical and pharmacological characterization Br J Pharmacol. 121:1997;171-180.
21. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA. 71:1974;345-349.
22. Schuster V.L. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol. 60:1998;221-242.
23. Zou M.H., Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 382:1996;101-104.
24. Zou M.H., Klein T., Pasquet J.-P., Ullrich V. Interleukin 1β decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation. Biochem J. 336:1998;507-512.
25. 2 synthase. characterization of mechanism-based inactivation with isolated enzyme and endothelial cells Arch Biochem Biophys. 321:1995;453-458.